The most important problem in medicine, and the case for acting now.
1 Comment so far
I think the article hits on a crucial point: medicine’s biggest bottleneck isn’t just treating disease after it appears, but preventing the underlying biological decline that drives most chronic conditions. If we can shift research and funding toward interventions that target aging mechanisms — like senolytics, metabolic regulators, or neuroprotective strategies — we might finally make a dent in the rising tide of multimorbidity. Acting now, even with modest pilot programs, could set the stage for a healthcare system that keeps people healthier longer rather than merely patching them up when they break.
I think the article hits on a crucial point: medicine’s biggest bottleneck isn’t just treating disease after it appears, but preventing the underlying biological decline that drives most chronic conditions. If we can shift research and funding toward interventions that target aging mechanisms — like senolytics, metabolic regulators, or neuroprotective strategies — we might finally make a dent in the rising tide of multimorbidity. Acting now, even with modest pilot programs, could set the stage for a healthcare system that keeps people healthier longer rather than merely patching them up when they break.